Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice

被引:40
作者
Luo, Junyong [1 ]
Cao, Jichao [1 ]
Jiang, Xueliang [2 ]
Cui, Huifei [1 ]
机构
[1] Shandong Univ, Inst Biochem & Biotechnol Drugs, Jinan 250012, Peoples R China
[2] Chinese PLA Gen Hosp Jinan Mil Command, Dept Gastroenterol, Jinan 2500312, Peoples R China
关键词
Ulcerative colitis; Rectal suppository; Low molecular weight heparin; INFLAMMATORY-BOWEL-DISEASE; FACTOR XA; UNFRACTIONATED HEPARIN; ALPHA PRODUCTION; STEM-CELL; IN-VITRO; MUSASHI-1; THERAPY; RAT; EFFICACY;
D O I
10.1016/j.biopha.2010.01.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The objective of this study was to investigate the effect and possible mechanism of rectally administered low molecular weight heparin (LMWH) on experimental ulcerative colitis. LMWH rectal suppository was prepared and its efficacy was studied by macroscopical and histological scoring systems as well as myeloperoxidase activity. Serum levels, including tumor necrosis factor-alpha (TNF alpha), interleukin-6 (IL-6) and a link factor of blood coagulation and inflammation factor Xa (FXa) were assayed by enzyme-linked immunosorbent assay. The expression of Musashi-1 (as an intestinal stem cell marker) in the colons was assessed by immunohistochemical analysis. The results showed that LMWH rectal suppository significantly decreased serum levels of TNF-alpha, IL-6 as well as FXa, while increased the expression of Musashi-1 in colon compared with acetic acid induced ulcerative colitis model group. All these preliminary results indicate LMWH rectal suppository is promising for treatment of ulcerative colitis. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 29 条
[1]
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease [J].
Ang, YS ;
Mahmud, N ;
White, B ;
Byrne, M ;
Kelly, A ;
Lawler, M ;
McDonald, GSA ;
Smith, OP ;
Keeling, PWN .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1015-1022
[2]
Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents [J].
Cahalon, L ;
Lider, O ;
Schor, H ;
Avron, A ;
Gilat, D ;
Hershkoviz, R ;
Margalit, R ;
Eshel, A ;
Shoseyev, O ;
Cohen, IR .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (10) :1517-1522
[3]
Efficacy of Intracolonic Administration of Low-Molecular-Weight Heparin CB-01-05, Compared to Other Low-Molecular-Weight Heparins and Unfractionated Heparin, in Experimentally Induced Colitis in Rat [J].
Celasco, Giuseppe ;
Moro, Luigi ;
Bozzella, Roberta ;
Mangano, Katia ;
Quattrocchi, Cinzia ;
Aiello, Caterina ;
Donia, Marco ;
Fagone, Paolo ;
Di Marco, Roberto .
DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (12) :3170-3175
[4]
Cui HF, 1999, WORLD J GASTROENTERO, V5, P448
[5]
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis - An open trial [J].
Dotan, I ;
Hallak, A ;
Arber, N ;
Santo, M ;
Alexandrowitz, A ;
Knaani, Y ;
Hershkoviz, R ;
Brazowski, E .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (10) :2239-2244
[6]
Treatment of corticosteroid-resistant ulcerative colitis with heparin - a report of 16 cases [J].
Evans, RC ;
Wong, VS ;
Morris, AI ;
Rhodes, JM .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) :1037-1040
[7]
In vitro and in vivo effects of gliotoxin, a fungal metabolite:: Efficacy against dextran sodium sulfate-induced colitis in rats [J].
Fitzpatrick, LR ;
Wang, J ;
Le, T .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (12) :2327-2336
[8]
Folwaczny C, 1999, AM J GASTROENTEROL, V94, P1551
[9]
Gonzalez-Lama Y, 2008, HEPATO-GASTROENTEROL, V55, P1609
[10]
Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo [J].
Herbert, JM ;
Bono, F ;
Hérault, JP ;
Avril, C ;
Dol, F ;
Mares, AM ;
Schaeffer, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :993-1000